medicalxpress.com
medicalxpress.com
rd.springer.com
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Preventing Adverse Events in CAR T-Cell Therapy: The Evolution of Safety Protocols
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
Poster Pearl: Treating ER+/HER2- mBC with Elacestrant and Endocrine Therapy
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
Sacituzumab Govitecan for mTNBC: A Review of Real-World Efficacy and Safety Data
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
Personalizing Care Within the Advanced RCC Treatment Paradigm: A Fireside Chat and Roundtable Symposium
Personalizing Care Within the Advanced RCC Treatment Paradigm: A Fireside Chat and Roundtable Symposium
February 13, 2025
07:30 PM - 09:00 PM PT
Overcoming Vaccine Hesitancy: Persuasive Conversation Strategies and Tips
Overcoming Vaccine Hesitancy: Persuasive Conversation Strategies and Tips
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Mastering CAR-T Cell Therapy in R/R Large B-Cell Lymphoma: Adverse Event Management
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Patient Partners in NSCLC: Collaborating to Enhance Quality of Life and Outcomes With EGFRi-Associated Dermatologic Toxicities
Tirzepatide reduces HF events in patients with HFpEF and obesity
Tirzepatide reduces HF events in patients with HFpEF and obesity
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Holistic AI Models Revolutionizing Cancer Detection and Treatment
Holistic AI Models Revolutionizing Cancer Detection and Treatment
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
Investigating the Incidence of IgA Nephropathy Among Racial and Ethnic Groups
AI and CRISPR: A Transformational Alliance in Medicine and Beyond
AI and CRISPR: A Transformational Alliance in Medicine and Beyond
AI in Precision Medicine Market Poised to Reach Nearly $4 Billion by 2030
AI in Precision Medicine Market Poised to Reach Nearly $4 Billion by 2030
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
New Hope Emerging in the Treatment of PTSD in Women: Overcoming Suboptimal Outcomes
Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection
Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer
Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
Treating Moderate-to-Severe Plaque Psoriasis in Patients 50+ Including the Medicare Population
Treating Moderate-to-Severe Plaque Psoriasis in Patients 50+ Including the Medicare Population
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Advancements in Understanding ALS Treatment
Advancements in Understanding ALS Treatment
Advancing the Transabdominal Cerclage Through Robotics
Advancing the Transabdominal Cerclage Through Robotics
The Time Is Now: Early Diagnosis and Intervention in Alzheimer’s Disease
The Time Is Now: Early Diagnosis and Intervention in Alzheimer’s Disease
